Synergistic Intestinal Anastomosis Treatment System

A novel system integrating surgical anchor devices with AI, IoT, blockchain, and advanced materials to enhance intestinal anastomosis treatment, providing real-time monitoring, secure data sharing, and personalized treatment planning.

The original patent disclosed a surgical anchor device for protecting intestinal anastomosis, but it lacked real-time monitoring, secure data sharing, and personalized treatment planning capabilities. The new inventive concept addresses these limitations by integrating the surgical anchor device with distinct technologies to create a more powerful and effective system.

The synergistic system comprises a surgical anchor device with a nitinol-based stent or shape-memory alloy-based stent, integrated with an AI-powered monitoring module for real-time tracking of anchor migration and anastomosis healing. The system also includes an IoT-enabled communication system for remote monitoring, a blockchain-based data storage system for secure and transparent data sharing, and advanced materials such as nanomaterial coatings for enhanced biocompatibility and tissue integration. The AI-powered analytics module provides personalized treatment planning and outcome prediction, while the wearable sensor device enables real-time patient monitoring.

The new claims introduce a synergistic combination of the surgical anchor device with AI, IoT, blockchain, and advanced materials, providing a novel and non-obvious solution for intestinal anastomosis treatment. The inventive step lies in the integration of these distinct technologies to create a more powerful and effective system, which is not obvious from the original patent.

Alternative embodiments of the inventive concept could include integrating the surgical anchor device with other AI-powered modules, such as predictive analytics or decision support systems. Variations could include using different types of advanced materials, such as graphene or biodegradable materials, or incorporating additional sensors or monitoring systems.

The synergistic intestinal anastomosis treatment system has significant commercial potential in the healthcare industry, particularly in the fields of gastrointestinal surgery and medical device development. The system's real-time monitoring, secure data sharing, and personalized treatment planning capabilities make it an attractive solution for hospitals, clinics, and medical research institutions.